Jamjoom Pharma

Home / Jamjoom Pharma

Saudi Binladin Group to resume construction on Jeddah Tower

Saudi Binladin Group to resume construction on Jeddah Tower

PLUS: Sama issues compliance + internal audit principles for finance,…

Earnings season is drawing to a close for Tadawul-listed companies

Earnings season is drawing to a close for Tadawul-listed companies

GIB Capital receives CMA approval for public offering of new equity fund

GIB Capital receives CMA approval for public offering of new equity fund

Sipchem inks refinancing agreement with BSF, AlRajhi. Plus: trade, pharma and infrastructure

Sipchem inks refinancing agreement with BSF, AlRajhi. Plus: trade, pharma and infrastructure

Acwa Power’s bottomline up in busy 1Q

Acwa Power’s bottomline up in busy 1Q

Jamjoom wants to make a type 2 diabetes drug in Saudi amid deeper push into localization

Jamjoom wants to make a type 2 diabetes drug in Saudi amid deeper push into localization

Jamjoom wants to line up SAR 36 mn in financing for its Algeria JV

Jamjoom wants to line up SAR 36 mn in financing for its Algeria JV

Also from our partner

Together with Vodafone

Business leaders spend their mornings with us.

Get EnterpriseAM — the daily newsletter now available in English and Arabic formats.